Streetbeat News

Analyst Ratings

CCCC

HC Wainwright & Co. analyst Andrew Fein maintains a 'Buy' rating on C4 Therapeutics (NASDAQ:CCCC), but has lowered the price target from $17 to $7.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:03 am

BRKR

Bruker Corporation (NASDAQ:BRKR) reported Q3 earnings of $0.74 per share, beating the analyst consensus estimate of $0.63 by 17.46%. The company also reported quarterly sales of $742.80 million, surpassing the analyst consensus estimate of $714.41 million by 3.97%. Both earnings and sales have increased compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:01 am

CORT

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains a 'Buy' rating on Corcept Therapeutics (NASDAQ:CORT) and raises the price target from $32 to $34.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:00 am

RVLV

Keybanc analyst Noah Zatzkin has downgraded Revolve Gr (NYSE:RVLV) from Overweight to Sector Weight.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:57 am

GKOS

Needham analyst David Saxon has maintained a 'Buy' rating on Glaukos (NYSE:GKOS), but lowered the price target from $89 to $83.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:54 am

STAA

Needham analyst David Saxon has maintained a 'Buy' rating on Staar Surgical (NASDAQ:STAA), but lowered the price target from $52 to $49.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:52 am

EL

Telsey Advisory Group has downgraded Estee Lauder Cos (NYSE:EL) from Outperform to Market Perform and lowered the price target from $210 to $115.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:49 am

ALKT

Needham analyst Mayank Tandon maintains a 'Buy' rating on Alkami Technology (NASDAQ:ALKT) and raises the price target from $21 to $24.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:47 am

ETSY

Needham analyst Anna Andreeva has maintained a 'Buy' rating on Etsy (NASDAQ:ETSY), but lowered the price target from $130 to $85.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:45 am

TPX

Tempur Sealy Intl (NYSE:TPX) has lowered its FY2023 adjusted EPS guidance from $2.50-$2.70 to $2.30-$2.50, which is below the analyst estimate of $2.60.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:44 am